IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 111
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2005 Clinical severity instruments Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S Contributo in libro
1-gen-2007 Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S Articolo su rivista
1-gen-2007 Long-term treatment of plaque psoriasis with efalizumab: an Italian experience Costanzo, A; Peris, K; Talamonti, M; Di Cesare, A; Fargnoli, Mc; Botti, E; Chimenti, S Articolo su rivista
1-gen-2008 Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S Intervento a convegno
1-gen-2008 Long-term efficacy of adalimumab in generalized pustular psoriasis Zangrilli, A; Papoutsaki, M; Talamonti, M; Chimenti, S Articolo su rivista
1-gen-2009 HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S Intervento a convegno
1-gen-2009 Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S Articolo su rivista
1-gen-2009 Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S Articolo su rivista
1-gen-2010 Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience Esposito, M; Giunta, A; Mazzotta, A; Babino, G; Talamonti, M; Chimenti, Ms; Chimenti, S Articolo su rivista
1-gen-2010 The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab Papoutsaki, M; Talamonti, M; Giunta, A; Costanzo, A; Ruzzetti, M; Teoli, M; Chimenti, S Articolo su rivista
1-gen-2011 Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis Talamonti, M; Galluzzo, M; Teoli, M; Bavetta, M; Chimenti, S; Costanzo, A Intervento a convegno
1-gen-2011 Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension Talamonti, M; Teoli, M; Botti, E; Spallone, G; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2011 Efalizumab Talamonti, M; Spallone, G; Di Stefani, A; Costanzo, A; Chimenti, S Articolo su rivista
1-gen-2012 Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study Teoli, M; Zangrilli, A; Chimenti, Ms; Talamonti, M; Bavetta, M; Graceffa, D; Perricone, R; Chimenti, S Articolo su rivista
1-gen-2012 Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome Talamonti, M; Galluzzo, M; Chiricozzi, A; Teoli, M; Bavetta, M; Costanzo, A; Chimenti, S Articolo su rivista
1-set-2012 Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A Intervento a convegno
1-set-2012 Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis Spallone, G; Botti, E; Talamonti, M; Marinari, B; Pinetti, V; Chimenti, S; Costanzo, A Intervento a convegno
1-gen-2013 Genetic variations in IL6 and IL12B as protective markers for psoriasis Boca, An; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, Ad; Costanzo, A Intervento a convegno
1-gen-2013 A phase II study of ponesimod in chronic plaque psoriasis: improvements in patient-reported outcomes Kemeny, L; Yankova, R; Talamonti, M; Vaclavkova, A; Burcklen, M; Thomas, G; D'Ambrosio, D Intervento a convegno
1-gen-2013 Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris Di Stefani, A; Galluzzo, M; Talamonti, M; Chiricozzi, A; Costanzo, A; Chimenti, S Articolo su rivista
Mostrati risultati da 1 a 20 di 111
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile